FDA Enforcement Class II Terminated

Hemocor High Performance Hemoconcentrator, HPH700, sterilized with ethylene oxide The Hemocor HPH700 Hemoconcentrator is intended for use as an ultrafiltration system to remove excess fluid during and/or following cardiopulmonary bypass procedures where acute hemodilution is employed.

Recall: Z-2761-2015 · Reported September 23, 2015

Enforcement

Recall Number
Z-2761-2015
Event ID
72122
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Medivators, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 23, 2015
Initiation Date
August 3, 2015
Classification Date
September 11, 2015
Termination Date
November 4, 2015
Address
14605 28th Ave N, Plymouth, MN, 55447-4822, United States

Description

Hemocor High Performance Hemoconcentrator, HPH700, sterilized with ethylene oxide The Hemocor HPH700 Hemoconcentrator is intended for use as an ultrafiltration system to remove excess fluid during and/or following cardiopulmonary bypass procedures where acute hemodilution is employed.

Reason

Hemoconcentrators may exhibit low ultrafiltration performance that is below product specification.

Code Info

Lot 759491A

Distribution

US Distribution to the states of CA and MI.

Quantity

840 units